| 发明名称 |
PHARMACEUTICAL COMPOSITION OF SILDENAFIL CITRATE IN THE FORM OF A SUSPENSION FOR ORAL USE |
| 摘要 |
The present invention refers to a pharmaceutical composition of sildenafil citrate in the form of a suspension for administration orally that comprises water as a vehicle and xanthan gum and hypromellose as suspension agents, that is highly stable and allows the efficient masking of the active ingredient's bitter taste. It also refers to a procedure for the preparation of said suspension and to a container that contains it and that is provided with a dosing device for its administration. This composition of sildenafil citrate in the form of a suspension is suitable for administration orally for the treatment of masculine sexual dysfunction. |
| 申请公布号 |
US2016279133(A1) |
申请公布日期 |
2016.09.29 |
| 申请号 |
US201615076858 |
申请日期 |
2016.03.22 |
| 申请人 |
Farmalider, S.A. ;Innovazone Labs LLC |
发明人 |
Martínez-Alzamora Fernando;Gómez Calvo Antonia;Rizo Martínez Miguel;Sanz Menéndez Nuria |
| 分类号 |
A61K31/519;A61K9/00;A61K47/36;A61K47/18;A61K47/12;A61K47/26;A61K47/22;A61K9/12;A61K47/38 |
主分类号 |
A61K31/519 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A pharmaceutical composition in the form of an aqueous suspension for oral administration comprising:
a) sildenafil citrate as the active ingredient, b) xanthan gum, and c) hypromellose. |
| 地址 |
Alcobendas (Madrid) ES |
